Skip to main content
. Author manuscript; available in PMC: 2013 Apr 8.
Published in final edited form as: Cell Cycle. 2009 Jul 23;8(14):2266–2280. doi: 10.4161/cc.8.14.9101

Figure 9.

Figure 9

VEGFR-3 knockdown decreases resistance to apoptosis in breast cancer cells. (A) Viability and (B) TUNEL assays of MCF7-VEGFR-3 shRNA stable clones treated for 24 hours with increased doses of Staurosporine. (C) Viability and (D) TUNEL assays of BT474 breast cancer cells shRNA stable clones treated for 24 hours with increased doses of Staurosporine. *p < 0.05; **p < 0.001 Viability data normalized as treated/untreated.